Invention Grant
- Patent Title: Combination formulation of two antiviral compounds
-
Application No.: US15393847Application Date: 2016-12-29
-
Publication No.: US10039779B2Publication Date: 2018-08-07
- Inventor: Ben Chal , Erik Mogalian , Reza Oliyai , Rowchanak Pakdaman , Dimitrios Stefanidis , Vahid Zia
- Applicant: Gilead Pharmasset LLC
- Applicant Address: US CA Foster City
- Assignee: Gilead Pharmasset LLC
- Current Assignee: Gilead Pharmasset LLC
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61K31/7072 ; A61K31/4184 ; A61K9/28 ; A61K31/7056 ; A61K31/4709 ; A61K9/16 ; A61K9/20 ; A61K31/513 ; A61K31/381 ; A61K31/4025 ; A61K31/497 ; A61K31/4985 ; A61K31/5025 ; A61K31/5377 ; A61K31/675 ; A61K31/7076 ; A61K31/4178 ; A61K9/24
Abstract:
Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.
Public/Granted literature
- US20170202865A1 COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS Public/Granted day:2017-07-20
Information query
IPC分类:
